What does Erythroleukemia mean?
Erythroleukemia is a subtype of acute myeloid leukemia (AML) that is distinguished by erythroblastic proliferation. Patients usuallly present with nonspecific signs and symptoms from the anemia, thrombocytopenia, and leukopenia resulting from the replacement of bone marrow by leukemic cells (see Presentation).
What causes Erythroleukemia?
Causes. The causes of AEL are unknown. Prior to a 2008 reclassification by the World Health Organization, cases that evolved from myelodysplastic syndromes, myeloproliferative neoplasms, chemotherapy for other cancers or exposure to toxins were defined as secondary AEL.
How do you treat Erythroleukemia?
Treatment and Prognosis The outcome is usually very poor for erythroleukemia. In de novo AML-M6b, treatment with intensive chemotherapy (anthracycline and cytarabine) gives a complete remission (CR) rate of approximately 50–60%.
What is the most common presentation of acute erythroid leukemia?
The most common presenting symptoms are as follows:
- Fatigue or malaise.
- Minimal-to-modest weight loss.
- Easy bruising.
- Fever.
- Bone or abdominal pain.
- Dyspnea.
- Meningeal signs and symptoms (very rare, only if leukemic involvement of the central nervous system [CNS] is present)
What are erythroleukemia cells?
Erythroleukemia: A form of acute myeloid leukemia (AML) that involves the cells that give rise to the erythrocytes (red blood cells). In erythroleukemia, the body produces large numbers of abnormal, immature red blood cells.
Is acute erythroleukemia curable?
Acute erythroleukemia (AEL) is a rare disease typically associated with a poor prognosis. The median survival ranges between 3–9 months from initial diagnosis.
Is acute Erythroleukemia curable?
What kind of cell line is erythroleukemia cells?
K562 cells were the first human immortalised myelogenous leukemia cell line to be established. K562 cells are of the erythroleukemia type, and the cell line is derived from a 53-year-old female chronic myelogenous leukemia patient in blast crisis.
What are Erythroblastic cells?
Definition of erythroblast : a polychromatic nucleated cell of red bone marrow that synthesizes hemoglobin and that is an intermediate in the initial stage of red blood cell formation broadly : a cell ancestral to red blood cells.
What is Diguglielmo disease?
First described in 1923 and named after Giovanni Guglielmo. It is classified as an M6 subtype of acute myeloid leukaemia (AML). It is characterised by large numbers of nucleated red cells appearing in the bone marrow and circulating blood volume.
What is the classification of erythroleukemia?
Erythroleukemia is a rare subtype of AML, which is categorized in the poor-risk group of AML (French-American-British [FAB] M6, or Di-Guglielmo’s disease <5%). Since the initial recognition, the diagnosis and classification of erythroleukemia has been significantly modified.
What are the markers of erythroleukemia?
The erythroblasts in erythroleukemia generally lack myeloid-associated markers and are negative with antimyeloperoxidase stains. The best known markers for erythroleukemia have included glycophorin A and CD36.
What is purepure acute erythroleukemia?
Pure acute erythroleukemia is a rare form of acute myeloid leukemia with predominant erythroid lineage proliferation. It is a heterogeneous entity amongst acute myeloid leukemia (AML) that can occur at any age, including childhood, and comprises less than 5% of AML.
Can erythroleukemia present as acute myeloid leukemia (AML)?
Latif and colleagues1 reported a case of erythroleukemia presenting as acute myeloid leukemia (AML) in a patient who was treated with a standard induction regimen. The patient experienced disease evolution and required treatment with salvage treatment, but expired due to disease progression.